Big Pharma Watch: Brand Name Drug Giant Caught Red Handed In Anti-Competitive Kickback Scheme

Sanofi Demonstrates How Brand Name Drug Companies Use Nonprofits to Keep Prices High & Pad Their Bottom Line Providing the latest example of the extremes Big Pharma will pursue in order boost

03-3-2020 Read More

What They Are Saying: Americans Continue to Demand Bipartisan Solutions to Hold Big Pharma Accountable, Lower Rx Prices

Voices from Around the Country Reiterate Need for Congress to Address Out-of-Control Prescription Drug Prices in 2020 Prescription drug prices are out-of-control and have left 58 million Americans

03-2-2020 Read More

Q4 EARNINGS: BIG PHARMA PRICE HIKES KEEP THE GOOD TIMES ROLLING

Top Brand Name Drug Companies Bank Sky-High Profits While Evading Accountability   And that’s a wrap! Over three weeks of earnings calls have proven, yet again, that hiking prices is a

02-18-2020 Read More

BIG PHARMA EARNINGS WATCH: ASTRAZENECA

Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Banked Sky-High Profits After Hiking Prices Earnings reports for the fourth quarter of 2019 provide the latest evidence that Big

02-14-2020 Read More

BIG PHARMA EARNINGS WATCH: ABBVIE

Big Pharma Giant Bests Wall Street Expectations After Hiking Prices In January   Yet another brand name drug company announced last week it had surpassed earnings expectations after hiking

02-10-2020 Read More

BIG PHARMA EARNINGS WATCH: MERCK, GLAXOSMITHKLINE & BRISTOL-MYERS SQUIBB

Brand Name Drug Companies Keep the Good Times Rolling for Shareholders by Price-Gouging American Patients This week, three more Big Pharma giants proved yet again that hiking prices is a profitable

02-7-2020 Read More

BIG PHARMA WATCH: ANTI-COMPETITIVE CHARITY SCHEMES TAKE CENTER STAGE AT WAYS & MEANS HEARING

Testimony Highlights How Brand Name Drug Companies Use Nonprofits To Keep Prices High & Pad Their Bottom Line   Expert witnesses at a Wednesday hearing before the U.S. House of

02-6-2020 Read More

DOSE OF REALITY: BIG PHARMA’S INSULIN PRICE PREDICAMENT

Pharmaceutical Companies to Blame for Out-of-Control Prices for Life-Saving Drug   During tonight’s State of the Union address, President Trump is expected to address the mounting crisis of

02-4-2020 Read More

CSRxP LAUNCHES SEVEN-FIGURE “PROMISE” CAMPAIGN URGING CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE

Comprehensive Effort Will Target D.C., In Addition To Nine Presidential & Senate Battleground States Calling For Passage of Bipartisan Solutions to Lower Prescription Drug Prices   For

02-4-2020 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.